PKC isozymes and diacylglycerol-regulated proteins as effectors of growth factor receptors.
Growth factors exert their cellular effects through signal transduction pathways that are initiated by the ligation of growth factors to their cell surface receptors. One of the well-established effectors of growth factor receptors is protein kinase C (PKC), a family of serine-threonine kinases that have been known for years as the main target of the phorbol ester tumor promoters. While there is abundant information regarding downstream PKC effectors and partners, how individual PKC isozymes become activated by growth factors and the regulation of receptor function by PKCs is only partially understood. Moreover, the identification of novel "non-kinase" DAG-binding proteins has added a new level of complexity to the field of DAG signaling.
Oliva
José Luis
JL
School of Medicine, University of Pennsylvania, Department of Pharmacology, Philadelphia, PA 19104-6160, USA.
Griner
Erin M
EM
Kazanietz
Marcelo G
MG
D000818:Animals; D004075:Diglycerides / Q000502:physiology*; D066246:ErbB Receptors / Q000502:physiology; D006133:Growth Substances / Q000502:physiology; D006801:Humans; D007527:Isoenzymes / Q000502:physiology; D009363:Neoplasm Proteins / Q000502:physiology; D010766:Phosphorylation; D011493:Protein Kinase C / Q000502:physiology*; D017434:Protein Structure, Tertiary; D019859:Proto-Oncogene Proteins c-met / Q000502:physiology; D017978:Receptors, Growth Factor / Q000502:physiology*; D015398:Signal Transduction
D004075:Diglycerides; D006133:Growth Substances; D007527:Isoenzymes; D009363:Neoplasm Proteins; D017978:Receptors, Growth Factor; C079844:beta-chimaerin; D066246:ErbB Receptors; D019859:Proto-Oncogene Proteins c-met; D011493:Protein Kinase C